Some commonly used antibiotics can save lives – but they can also damage hearing. RNID‑funded research is working to find ways to prevent or reduce hearing loss caused by a class of antibiotics known as aminoglycosides. This is Cystic Fibrosis Awareness Week....
No actionable change — this is an awareness blog about ongoing funded research, not a completed study with clinical findings.
Aminoglycoside-induced ototoxicity remains an unsolved clinical problem for cystic fibrosis and other patient populations, and RNID-backed research signals growing charitable investment in finding protective strategies.
- 01RNID is funding research targeting hearing loss caused by aminoglycoside antibiotics.
- 02Aminoglycosides are widely used in cystic fibrosis care and can cause permanent hearing damage.
- 03The blog was published to coincide with Cystic Fibrosis Awareness Week.
- 04The piece is awareness-raising rather than a report of completed research results.
- 05No protective intervention or clinical outcome data is presented.
Aminoglycoside antibiotics can cause ototoxic (medication-related) hearing loss.
guidelinesupportedRNID-funded research aims to prevent or reduce ototoxic hearing loss from aminoglycosides.
press releaseunclear